Area of research
Hepatology · Cancer Research
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, MicroRNA in disease regulation, Cholangiocarcinoma and Gallbladder Cancer Studies, and Inflammatory Biomarkers in Disease Prognosis.
FOXO6 specifically promotes Rac1 overactivation drives Hepatocellular Carcinoma migration and Early Recurrence: FOXO6 as a novel Therapeutic Target for Liver Cancer
Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics Perspective
A N7-methylguanosine modified circular RNA, circIPP2A2, promotes malignant behaviors in hepatocellular carcinoma by serving as a scaffold in modulating the Hornerin/PI3K/AKT/GSK3β axis
FOXO6 specifically mediates overactivation of Rac1 in hepatocellular carcinoma
Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection
Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer
Prognostic value of combined preoperative prognostic nutritional index and body mass index in HCC after hepatectomy
A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI)
Risk factors and outcomes of postoperative pancreatic fistula after pancreatico-duodenectomy: an audit of 532 consecutive cases
The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma
Prognostic value of preoperative serum gamma-glutamyltranspeptidase in patients with hepatocellular carcinoma after hepatectomy
Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis
Preoperative Aspartate Aminotransferase to Platelet Ratio is an Independent Prognostic Factor for Hepatitis B-Induced Hepatocellular Carcinoma After Hepatic Resection
Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection